- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05851573
Stepped Care for Aphasia
February 3, 2025 updated by: Deena Blackett, Medical University of South Carolina
Stepped Care Model of Psychological Care for Aphasia
This study is recruiting people who had a stroke at least 1 month ago and now have a language impairment called aphasia.
Living with aphasia can have devastating effects on communication and quality of life, and it is not uncommon for survivors with aphasia to face psychological problems like depression and anxiety.
Participants who are eligible for this study will undergo baseline testing, engage in a 5-week treatment focused on psychological well-being, undergo post-treatment testing, and then testing again 1-month later.
Check-in phone calls will be conducted during the 1-month off period and participants will be interviewed about their experience at the end of the study as well.
Compensation will be provided to participants with aphasia.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18-81 years old
- Native English speaker (English fluency by age 7)
- Aphasia as a result of a left-hemisphere ischemic or hemorrhagic stroke (WAB-R Aphasia Quotient < 93.8)
- At least 1-month post-stroke
- Confirmation of left hemisphere stroke per medical records
- Discharged from hospital
- Participant is willing and able to consent for themselves.
Exclusion Criteria:
- Uncorrected hearing or visual impairment that prevents completion of experimental activities as determined by self-report
- History of other neurological disorder or disease beside stroke (e.g., dementia, traumatic brain injury) as determined by self-report and/or medical records
- Self-reported history of premorbid learning disability
- Severe auditory comprehension deficits (as indicated by a score of more than two standard deviations below norms on the Auditory Verbal section of WAB-R)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Psychosocial intervention
|
an SLP-administered 5-week treatment focused on psychological well-being
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Depression Score on Hospital Anxiety and Depression Scale at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Change in the total depression Hospital Anxiety and Depression Scale scores between baseline and post-treatment (baseline-post-treatment). Minimum score 0, maximum score 21.
Positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.
|
through intervention completion, an average of 7 weeks
|
|
Change in the Anxiety Score on Hospital Anxiety and Depression Scale at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Change in the total anxiety Hospital Anxiety and Depression Scale scores between baseline and post-treatment (baseline-post-treatment). Minimum score 0, maximum score 21.
Positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.
|
through intervention completion, an average of 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Dynamic Visual Analogue Mood Scales at Post-Intervention
Time Frame: through study completion, an average of 7 weeks
|
Total summary score (min: 0, max: 100, higher scores indicate better outcome) and sadness score (min: 0, max: 100, higher scores indicate better outcome) (baseline-post-treatment). Positive number indicate worsening in mood, negative numbers indicate an improvement in mood.
|
through study completion, an average of 7 weeks
|
|
Change in Stroke Aphasia Depression Questionnaire - 10 at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Total score (min: 0, max: 30, higher scores indicate worse outcome); baseline-post-treatment; positive scores indicate improvement in symptoms, negative score indicate worsening of symptoms
|
through intervention completion, an average of 7 weeks
|
|
Change in Behavioural Outcomes of Anxiety Scale at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Total score (min: 0, max: 30, higher scores indicate worse outcome); baseline-post-intervention; positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.
|
through intervention completion, an average of 7 weeks
|
|
Change in Modified Perceived Stress Scale at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Total score (min: 0, max: 40, higher scores indicate worse outcome); baseline-post-intervention; positive numbers indicate an improvement in symptoms, negative numbers indicate a worsening in symptoms
|
through intervention completion, an average of 7 weeks
|
|
Change in Stroke Aphasia Quality of Life - 39 at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Total score (min: 1, max: 5), baseline-post-intervention, positive numbers indicate a worsening of quality of life, negative numbers indicate an improvement in quality of life
|
through intervention completion, an average of 7 weeks
|
|
Change in Communication Confidence Rating Scale for Aphasia at Post-Intervention
Time Frame: through intervention completion, an average of 7 weeks
|
Total score (min: 10, max: 40, higher scores indicate better confidence); baseline-post-intervention, positive numbers indicate a worsening in communication confidence and negative numbers indicate an improvement in communication confidence
|
through intervention completion, an average of 7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 31, 2023
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
April 7, 2023
First Submitted That Met QC Criteria
May 1, 2023
First Posted (Actual)
May 9, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 3, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00125313
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on Psychosocial intervention
-
University of Southern MississippiMy Brother's KeeperCompletedCardiovascular DiseasesUnited States
-
IVI SevillaIVI MadridCompletedAnxiety Depression | Psychosocial Stressor | Infertility Primary
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated
-
College of Professional and Continuing Education...SuspendedInsomnia | Randomised Controlled TrialHong Kong
-
University of Lausanne HospitalsCompletedGestational Diabetes MellitusSwitzerland
-
Sykehuset Innlandet HFNorwegian Medical AssociationCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMalignant Neoplasm | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Teesside UniversityUniversity of Manchester; Jos University Teaching HospitalNot yet recruitingStress | Anxiety | Trauma | Depression, Anxiety | Child Behaviour | Woman Abuse | Parenting Intervention
-
Duke UniversityCompletedBreast CancerUnited States
-
The Mediterranean Institute for the Advance of...Carlos III Health Institute; Andaluz Health Service; Preventive Services and...Completed